Armata Pharmaceuticals, Inc. Common Stock

Go to Armata Pharmaceuticals, Inc. Common Stock Website

$2.59

(%)
Live
Previous Close

$2.59

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$93.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

NYSE American, LLC

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is devel...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Y-mAbs Therapeutics, Inc. (YMAB) delivered earnings and revenue surprises of -12.50% and 0.53%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: YMAB, ARMP.

Read Full Article

Armata Pharma (ARMP) stock skyrockets 130% in a month due to encouraging progress of the company's pathogen-targeting natural and synthetic phage candidates.

Related tickers: DVAX, JNJ, CORT, ARMP.

Read Full Article
Trending Tickers
CTMX

XNAS

$1.89
(%)
MIMO

XASE

$0.11
(%)
PRSO

XNAS

$1.38
(%)
QQQ

XNAS

$451.76
(%)
$0.00
(%)